The Winter 2017 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and testing new treatments for squamous cell lung cancer.

The newsletter has the latest on a reopened sub-study, a trial update at the World Conference on Lung Cancer last month in Japan, and a December 7 webinar for site staff, who can get the study status and all their questions answered by Lung-MAP leaders on the call. Read the new edition here.